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ABSTRACT   
The effect of Calotropis gigantea (CG) leaves extract on fibrosarcoma growth and Caspase 3 expression have been 
evaluated. Mile mice were divided into 5 groups with 7 mice per group, (1) Negative control (CMC-Na 0.5%), (2) Positive 
control (Methotrexate 2,5 mg/kgBW), (3) 50 mg/Kg BW of CG, (4) 100 mg/Kg BW of CG, (5) 150 mg/Kg BW of CG.  
Mice body weights were observed before induced by cancer agent. Then, all mice were injected by 0.1 mL DMBA 25 
μg/0.1 mL acetone by subcutaneous injection two times a week for 6 weeks. After treatment, all mice were sacrificed by 
euthanasia method based on Guideline for the Euthanasia of Animals. Then, mice nodules were taken and washed with 
PBS. Nodules were weighted and kept in the formaldehyde solution. Then immunohistochemical caspase-3 specimens 
were made. C. gigantea leaves extract at a dose of 100 and 150 mg/Kg BW were able to inhibit the growth of fibrosarcoma 
in experimental animals induced DMBA. This extract also improved the apoptotic index of cell, respectively for 20.9 %; 
21.5 % and 24.6 %, and increased the caspase-3 expression significantly. Based on those data, C. gigantea leaves ethanol 
extract was potential to develop as anticancer phytopharmaca agent. 
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INTRODUCTION 
Cancer is a leading global cause of death and disability, 
and responsible for approximately 7.6 million deaths each 
year1. The failure of chemotherapy treatment is due to low 
selectivity of anticancer drugs on normal cell and cancer 
cell resistance to chemotherapeutics agents that cause 
serious side effects in patient. Calotrophis gigantea 
(Apocynaceae) is a traditional medicinal plant that grows 
widely in Asia (Bangladesh, Burma, China, India, 
Indonesia, Malaysia, Pakistan, Philippine, Thailand and 
Srilanka) and Africa (Sudan, Kenya, Tanzania, Gabon, 
Zaire, Angola, Mozambique, Mauritius, Seychelles)2,3. In 
Indonesia, this plant have been used to cure diseases, e.g. 
itching, scabies, blain, cough, trachoma, constipation 
(leaves), asthma, nausea, stomach-ache (flower), 
gonorrhoea, snake poisoned (root), toothache, swollen, ear 
inflammation, wormy, and disentry4.Previous studies 
reported that C. gigantea was potential to be anticancer 
agent. Cytotoxic activity of cardenolid which was isolated 
from C. gigantea leaves was reported against MCF-7 
cancer cell, KB-skin cancer cell, NCL-H18-lung cancer 
cell5; Dichloromethane extract of C. gigantea  leaves was 
showed cytotoxic activity against MCF-7 cancer cell, 
MDA-MB-231 cancer cell, HeLa cell, HT-29 cancer cell, 
SKOV-3 cancer cell, Hep-G2 cancer cell6. Calotropon 
which was isolated from roots had cytotoxic activity in 
K562 leukaemia and stomach cancer 7907. Methanol 
extract and chloroform fraction of the root have antitumor 
activity on ascites carcinoma8. Anhydrosophoradiol-3-
acetate (A3A) isolated from the flower was inhibited the 
growth of EAC (Ehrlich Ascites Carcinoma) effectively9. 
It has been known that cardio glycoside compound isolated 
from the root was capable to inhibit the growth of HeLa 
cell and A549 cancer cell10. Based on the previous reported 
data, this research aims to investigate anticancer activity of 
C. gigantea ethanolic leaves extract on fibrosarcoma using 
experimental animal in vivo, and to determine the 
mechanism through apoptotic induction with caspase-3 
expression as the parameter. 
 
MATERIALS AND METHODS 
Plant material 
Widuri (Calotropis gigantea) was obtained from Lembaga 
Ilmu Pengetahuan Indonesia (LIPI) Purwodadi, Jawa 
Timur. Authentication and identification of plant was 
carried out at Lembaga Ilmu Pengetahuan (LIPI) 
Purwodadi Jawa Timur. 
Animals  
Experimental animal for anticancer test was white male 
mice (Mus musculus) furrow Balb/C obtained from Gadjah 
Mada University, Jogjakarta. The mice had 20 – 30 g body 
weight and maintained on standard animal pellets and 
water ad libitum at animal laboratory, Faculty of Science 
and Technology, Universitas Islam Negeri, Malang. 
Permission and approval for animal studies were obtained 
from Faculty of Medicine, Universitas Brawijaya. 
Chemicals and reagents 
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Methotrexate, 7,12-Dimethylbenz(α) antrasene (DMBA), 
acetone, CMC-Na, sawdust, paraffin, glycerin, ethanol p.a 
(100 %, 90 %, 80 %, 70 %), xylol, PBS, H2O2, primary 
antibody caspase-3, secondary antibody Antirabbit IgG, 
biotin, SA-HRP (Sterp Avidin-Horseradish Peroxidase) 
(Daco), DAB substmicee (Amresco), Meyers Hematoxylin 
(IHC World). 
Plant extraction  
Calotropis gigantea leaves were washed and cut into small 
size, then placed in the oven with temperature of 40 oC. 
Dried leaves were grinded by steamroller 90 meshes. 
Extraction was using ethanol 70 % as a solvent. Ethanol 
extract was further concentrated by rotary evaporator and 
placed in the oven with temperature of 40 0C.  
Anticancer assay 
Total 35 mice were adapted for ± 5 days and divided into 
5 groups with 7 mice per group. Mice body weights were 
observed before induced by cancer agent. Then, all mice 
were injected by 0.1 mL DMBA 25 μg/0.1 mL acetone by 
subcutaneous injection two times a week for 6 weeks11. 
The groups were: Negative control group were treated with 
CMC-Na 0.5% once a day for 14 days. Positive control 
group were treated with Methotrexate at a dose of 2,5 
mg/kgBW once a week for two weeks. First dosage group 
were treated with C. gigantea leaves extract at a dose of 50 
mg/kg BW once a day for 14 days. Second dosage group 
were treated with C. gigantea leaves extract at a dose of 
100 mg/kg BW once a day for 14 days. Third dosage group 
were treated with C. gigantea leaves extract at a dose of 
150 mg/kg BW once a day for 14 days. After treatment, all 
mice were sacrificed by euthanasia method based on 
Guideline for the Euthanasia of Animals (by inhalation of 
ether or chloroform)12. Then, mice nodules were taken and 
washed with PBS. Nodules were weighted and kept in the 
formaldehyde solution. Then immunohistochemical 
caspase-3 specimens were made. 
Immunohistochemical Caspase-3 
Caspase-3 assay was conducted by immunohistochemical 
colouring standard procedure (10). Caspase-3 polyclonal 
antibody (rabbit polyclonal anti-mouse caspase-3) (Dako) 
was used as primary antibody and (anti rabbit biotin 
conjugated) (Dako) as secondary antibody. Microscopic 
expression of caspase-3 was observed from the brownish 
colour that caused by antibody anti caspase-3 reaction 
visualised by chromogen DAB (Sigma). The assay was 
done in triplicates.  Total expression of caspase-3 was 
measured by counting the fibroblast cells that showed 
brownish colour using light microscope (Olympus) at 20 
field of view with a 400 times magnification. Apoptotic 
index was determined by the equation 
below13: Apoptotic Index (AI) =
apoptotic cell
total cell
 x 100 % 
Apoptotic index was defined as presentation of apoptotic 
cell from 1000 cancer cells on 20 fields of view. Apoptotic 
cell was identified as cell that showed brown colour in its 
cytoplasm. Analysis also conducted by Allred scoring 
method to determine the semi quantitative IHK score. IS 
value was showed intensity score, which were scored as 0 
(negative or no brown colour), 1 (weak brown colour), 2 
(medium brown colour) and 3 (strong brown colour). IP 
value was showed the presentation of brown colour, which 
were scored as 0 (no brown colour), 1 (≤1/100 brown 
cells), 2 (≤1/10 smeared cells), 3 (≤1/3 smeared cells), 4 
(≤2/3 smeared cells), and 5 (all cells are smeared). Total 
sum of IS value and IP value was total score of IHK13. 
 
RESULTS AND DISCUSIONS 
Induced Mice by DMBA 
  
Figure 1: Scoring Allred13 Figure 2: Body weight changes for animals. The mice body 
weight when induced by DMBA (1-12) and treatment (13-26). 
  
Table 1: Results of mice body weight and fibrosarcoma incidence observation. 
Group 
% Increasing body weight 
±SD1 
Average of tumour weight 
±SD2 
Tumour 
Incidence 
Dosage 50 mg/Kg BW 30.00 ± 2.00 102.3±1.27 40 % 
Dosage 100 mg/Kg BW 30.20 ± 2.16 122.05±1.9 20 % 
Dosage 150 mg/Kg BW 28.80 ± 1.78 83.3±2.83 20 % 
Methotrexate 2.5 mg/Kg BW 27.80 ± 6.14 45.1±1.41 40 % 
Negative control CMC-Na 0.5% 22.40 ± 4.88 146.4±3.11 40 % 
1value showed average of mice body weight ± standard deviation 
2value showed average of tumour weight ± standard deviation 
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Body weight was one kind of respond that showed the 
growth of the mice since induced by DMBA. Mice body 
weight observation from 1st until 12th DMBA induction 
was shown an increase and decrease in unstable. In the 
DMBA induction at 4th, 8th, 11th and 12th, the average of 
mice body weight in all treatment groups experienced a 
decline. Mean, when extract treatment was conducted, the 
mice body weight tend to be more stable at 13th until 36th 
 
Figure 3: The result of IHK Caspase-3, zoom: 400x, a) negative control, CMC-Na 0.5 %, b) positive control 
Methotrexate 2.5 mg/Kg BW, c) dosage 50 mg/Kg BW, d) dosage 100 mg/Kg BW, e) dosage 150 mg/Kg BW. Those 
arrows show the cells that have expression of caspase-3 (apoptotic). 
 
Table 2: The analysis result of apoptotic index and IHK caspase-3 score 
Group Live 
Cell 
Death 
Cell 
Apoptotic Index (AI) 
(%) 
Increasing AI 
(%) 
IHK Caspase-3 
Score1 
Negative control 921 79 7.9 0 3.90 ± 0.57 
Positive control 819 181 18.1 10.2 4.00 ± 0.47 
Dosage 50 mg/Kg BW 712 288 28.8 20.9 4.70 ± 1.06 
Dosage 100 mg/Kg BW 707 294 29.4 21.5 5.30 ± 0.82 
Dosage 150 mg/KgBW 675 325 32.5 24.6 5.50 ± 0.53 
1 value shows average of IHK caspase-3 score ± standard deviation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) 
(c) 
(d) 
(e) 
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measurement. Stability of mice body weight possibly 
caused by pains less and lack of stress because of 
termination of DMBA induction during treatment period. 
The mice body weight was increased since first until last 
treatment (figure 2). Statistical analysis showed that 
treatment had influenced on mice body weight. The result 
of One Way ANOVA assay was p = 0.026 (p<0.05), it 
showed that there was a significant difference in all 
treatment groups. The Post Hoc analysis result showed that 
there was significant difference between group at a dose of 
50 mg/Kg BW and negative control group with p = 0.037 
(p<0.05), then group at a dose of 100 mg/Kg BW and 
negative control group with p = 0.031 (p<0.05). Treatment 
group with C. gigantea leaves extract at a dose of 100 and 
150 mg/Kg BW showed lower fibrosarcoma insidence 
than negative control group. C. gigantea leaves extract at 
a dose of 100 and 150 mg/Kg BW were capable to diminish 
fibrosarcoma incidence and inhibited fibrosarcoma 
growth. The result was equal to tumour weight that formed 
after treatment. When C. gigantea leaves extract dosage 
was increased, the tumour weight was decreased. 
Immunohistochemical (IHK) Caspase-3 
IHK analysis was used to know the apoptotic cell as the 
parameter of body immune system reaction in inhibited the 
growth of cancer. The principle of IHK analysis was 
antibody bonded antigen specifically. Antibody-antigen 
bonding was formed between conjugated antibody and 
peroxidase (catalytic enzyme that can give specific 
colour). This antibody-antigen bonding can be located in 
the cytoplasm or in the cell core that was showed by brown 
colour14. Based on analysis of index apoptotic, it indicated 
that increasing the dosage of C. gigantea leaves extract can 
increase the apoptotic index. The result of apoptotic 
analysis and IHK caspase-3 score was presented on table 
1. The result of Kruskal-Wallis assay showed ‘p’ value 
0.000 (p<0.05), it means that there was a significant 
difference between treatment groups. Then the next 
analysis is Mann-Whitney assay, and IHK score from this 
assay in treatment group with dosage 50, 100, and 150 
mg/Kg BW ( p value <0.05) shows that there was a 
significant difference to the negative control group. This 
result indicated that C. gigantea leavesextract able to 
increase caspase-3 expression at induced mice by DMBA. 
Result of this caspase-3 score was correlated with 
increasing of apoptotic index and decreasing tumour 
weight. Inhibition of fibrosarcoma growth and increasing 
of caspase-3 expression caused by C. gigantea leaves 
extract treatment were suspected because of cardiac 
glycosides (CGs) in this extract. CGs compound that 
isolated from C. Gigantea leaves were reported, including 
19-Nor- and 18,20-Epoxy-cardenolides, calotropin, 
calotropogenin5. Based on in vivo study, CGs compound 
known had high anticancer activity on some types of breast 
cancer, lung cancer, prostate, melanoma, neuroblastoma, 
myeloma, and leukemia15. And also showed the inhibition 
on skin carcinogenesis, lung cancer and decrease tumour 
weight16-18. Based on clinical test, cardiac glycosides were 
proved to have anticancer activity at breast cancer 
patient18. The mechanism of apoptotic induction and cell 
proliferation inhibition of CGs compound were known 
from alteration pathway in homeostasis of K+, Na+ and 
Ca2+, induction of mitochondrial pathway and inhibition of 
TNF/NF-κβ18,19. 
 
CONCLUSION 
C. gigantea leaves extract at a dose of 100 and 150 mg/Kg 
BW were able to inhibit the growth of fibrosarcoma in 
experimental animals induced DMBA. This extract also 
improved the apoptotic index of cell, respectively for 20.9 
%; 21.5 % and 24.6 %, and increased the caspase-3 
expression significantly. Based on those data, C. gigantea 
leaves ethanol extract was potential to develop as 
anticancer phytopharmaca agent. 
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